{
    "organizations": [],
    "uuid": "18174cb571944c0049eedd9972cd528e8286c8ab",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-adaptimmune-therapeutics-says-on-j/brief-adaptimmune-therapeutics-says-on-jan-5-co-entered-into-agreement-with-cell-gene-therapy-catapult-for-vector-production-in-uk-idUSFWN1P30PX",
    "ord_in_thread": 0,
    "title": "BRIEF-Adaptimmune Therapeutics Says On Jan 5, Co Entered Into Agreement With Cell, Gene Therapy Catapult For Vector Production In UK",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 8 (Reuters) - Adaptimmune Therapeutics Plc:\n* ADAPTIMMUNE THERAPEUTICS SAYS ON JAN 5, CO ENTERED INTO AGREEMENT WITH CELL AND GENE THERAPY CATAPULT FOR VECTOR PRODUCTION IN UK - SEC FILING\n* ADAPTIMMUNE THERAPEUTICS - AGREEMENT IS FOR TERM OF 5 YEARS WITH EARLIER TERMINATION AVAILABLE TO BOTH PARTIES ON PROVISION OF 12 MONTHSâ€™ NOTICE\n* ADAPTIMMUNE THERAPEUTICS PLC - AGREEMENT WILL ENABLE CO TO HAVE ITS OWN DEDICATED VECTOR MANUFACTURING SPACE IN UK\n* ADAPTIMMUNE - AGREEMENT TO ENSURE VECTOR SUPPLY PRODUCTION BEYOND 2020 FOR ONGOING STUDIES WITH 3 SPEAR T-CELL THERAPIES, MAGE-A4, MAGE-A10 AND AFP Source text ( bit.ly/2m7wkSH ) Further company coverage:\n ",
    "published": "2018-01-08T21:22:00.000+02:00",
    "crawled": "2018-01-09T17:19:27.029+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "adaptimmune",
        "therapeutic",
        "plc",
        "adaptimmune",
        "therapeutic",
        "say",
        "jan",
        "co",
        "entered",
        "agreement",
        "cell",
        "gene",
        "therapy",
        "catapult",
        "vector",
        "production",
        "uk",
        "sec",
        "filing",
        "adaptimmune",
        "therapeutic",
        "agreement",
        "term",
        "year",
        "earlier",
        "termination",
        "available",
        "party",
        "provision",
        "month",
        "notice",
        "adaptimmune",
        "therapeutic",
        "plc",
        "agreement",
        "enable",
        "co",
        "dedicated",
        "vector",
        "manufacturing",
        "space",
        "uk",
        "adaptimmune",
        "agreement",
        "ensure",
        "vector",
        "supply",
        "production",
        "beyond",
        "ongoing",
        "study",
        "spear",
        "therapy",
        "afp",
        "source",
        "text",
        "company",
        "coverage"
    ]
}